Jamieson Wellness (TSE:JWEL) had its target price hoisted by Royal Bank of Canada from C$23.00 to C$24.00 in a report released on Friday morning. The firm currently has an outperform rating on the stock.
Other equities analysts also recently issued research reports about the stock. BMO Capital Markets upped their price objective on shares of Jamieson Wellness from C$22.00 to C$26.00 in a report on Friday. CIBC upped their price objective on shares of Jamieson Wellness from C$20.60 to C$22.00 in a report on Friday, February 16th. Canaccord Genuity restated a buy rating and set a C$24.00 price objective on shares of Jamieson Wellness in a report on Monday, October 30th. TD Securities upped their price objective on shares of Jamieson Wellness from C$22.00 to C$24.00 and gave the company a buy rating in a report on Monday, November 13th. Finally, National Bank Financial upped their price objective on shares of Jamieson Wellness from C$22.25 to C$24.75 and gave the company an outperform rating in a report on Friday, January 5th. Seven investment analysts have rated the stock with a buy rating, The stock has a consensus rating of Buy and an average price target of C$23.96.
Jamieson Wellness (JWEL) opened at C$20.55 on Friday. Jamieson Wellness has a fifty-two week low of C$16.44 and a fifty-two week high of C$22.90. The stock has a market cap of $782.95 and a PE ratio of -13.70.
About Jamieson Wellness
Jamieson Wellness Inc is a Canada-based company, which operates as the health and wellness company. The Company develops, manufactures and markets brand of vitamins and natural health products. The Company offers vitamins, minerals and supplements (VMS) products and certain over-the-counter remedies through Jamieson and LVHS brands as well as sports nutrition products through Progressive, Precision and Iron Vegan brands.
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.